Oncolytics Biotech Inc (NASDAQ:ONCY)

0.889
Delayed Data
As of 3:59pm ET
 -0.011 / -1.22%
Today’s Change
0.35
Today|||52-Week Range
2.69
-50.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$23.4M

Company Description

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Contact Information

Oncolytics Biotech, Inc.
1167 Kensington Crescent NW
Calgary Alberta T2N 1X7
P:(403) 670-7377
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

There are no executives to display.